The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Dallas Matthew D since year 2005.
The trader's CIK number is 1612396.
At the time of this reporting, Dallas Matthew D is the Chief Financial Officer of Colucid Pharmaceuticals, Inc. .
(stock ticker symbol CLCD).
See this page for all insider trading activities at Colucid Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-01-03||CLCD||Colucid Pharmaceuticals, Inc.||Sale||1,473||36.25||53,396|
|2016-12-01||CLCD||Colucid Pharmaceuticals, Inc.||Sale||1,473||35.17||51,800|
|2015-01-16||AVEO||Aveo Pharmaceuticals Inc||Sale||3,075||.82||2,512|
|2015-01-07||AVEO||Aveo Pharmaceuticals Inc||Sale||519||.80||415|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dallas Matthew D (Chief Financial Officer of Colucid Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.